Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Vlassov

Showing results (11-20 of 313) with videos related to

Pageof 32
Sort By:
Nucleosides & Nucleotides|September 4, 1999
Activation of spleen lymphocytes by plasmid DNAE Rykova, P Laktionov, V Vlassov
Genetica|January 1, 1991
Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probesD G Knorre, V V Vlassov
Value in Health Regional Issues|April 19, 2021
May the Cleaning of Prescriptive Documents Using Best Evidence Reduce the Cost of Prescribed Healthcare?Yulia A Ledovskikh, Vasiliy V Vlassov
The Cochrane Database of Systematic Reviews|April 21, 2006
Low level laser therapy for treating tuberculosisV V Vlassov, H G MacLehose
Health Economics, Policy, and Law|October 5, 2019
Quality improvement in hospitals in the Russian Federation, 2000-2016: a systematic reviewVasiliy V Vlassov, Katie Bates, Martin McKee
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2011
Optimization of transfection conditions and analysis of siRNA potency using real-time PCRAngie Cheng, Susan Magdaleno, Alexander V Vlassov
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2011
Quantification of siRNAs in vitro and in vivoAngie Cheng, Alexander V Vlassov, Susan Magdaleno
Oligonucleotides|September 19, 2006
Binary hammerhead ribozymes with improved catalytic activityM Vorobjeva, M Zenkova, A Venyaminova, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2008
Synthesis and application of a new 2',3'-isopropylidene guanosine substituted cap analogAnilkumar R Kore, Muthian Shanmugasundaram, Alexander V Vlassov
Nucleosides & Nucleotides|September 4, 1999
Interaction of complementary oligonucleotides with the 3'-end of yeast tRNA(Phe)V Petyuk, M Zenkova, R Giege, et al.
Pageof 32

Showing results (11-20 of 313) with videos related to

Sort By:
Pageof 32
Nucleosides & Nucleotides|September 4, 1999
Activation of spleen lymphocytes by plasmid DNAE Rykova, P Laktionov, V Vlassov
Genetica|January 1, 1991
Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probesD G Knorre, V V Vlassov
Value in Health Regional Issues|April 19, 2021
May the Cleaning of Prescriptive Documents Using Best Evidence Reduce the Cost of Prescribed Healthcare?Yulia A Ledovskikh, Vasiliy V Vlassov
The Cochrane Database of Systematic Reviews|April 21, 2006
Low level laser therapy for treating tuberculosisV V Vlassov, H G MacLehose
Health Economics, Policy, and Law|October 5, 2019
Quality improvement in hospitals in the Russian Federation, 2000-2016: a systematic reviewVasiliy V Vlassov, Katie Bates, Martin McKee
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2011
Optimization of transfection conditions and analysis of siRNA potency using real-time PCRAngie Cheng, Susan Magdaleno, Alexander V Vlassov
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2011
Quantification of siRNAs in vitro and in vivoAngie Cheng, Alexander V Vlassov, Susan Magdaleno
Oligonucleotides|September 19, 2006
Binary hammerhead ribozymes with improved catalytic activityM Vorobjeva, M Zenkova, A Venyaminova, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2008
Synthesis and application of a new 2',3'-isopropylidene guanosine substituted cap analogAnilkumar R Kore, Muthian Shanmugasundaram, Alexander V Vlassov
Nucleosides & Nucleotides|September 4, 1999
Interaction of complementary oligonucleotides with the 3'-end of yeast tRNA(Phe)V Petyuk, M Zenkova, R Giege, et al.
Pageof 32